Pacol, Merilyn A.
HRN: 25-83-69 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/06/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
09/06/2024
09/13/2024
IV
600mg
Every 8 Hours
Infected Wound
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes